Menu

Biology, Genetics & Bone Healing MCQs

Practice Set 45 of 212

This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.

Question 881

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with knee pain. Radiographs show an eccentric, lytic lesion in the epiphysis of the proximal tibia extending to the subchondral bone, with no sclerotic margin. Biopsy shows multinucleated giant cells in a stroma of mononuclear cells. Which monoclonal antibody is approved for treating unresectable or recurrent forms of this tumor?

. Infliximab
. Denosumab
. Rituximab
. Bevacizumab
. Trastuzumab

Correct Answer & Explanation

. Denosumab

Explanation

The lesion described is a Giant Cell Tumor of bone (GCT). The mononuclear stromal cells express RANKL, which recruits and stimulates osteoclast-like giant cells causing osteolysis. Denosumab is a monoclonal antibody against RANKL and is highly effective in treating unresectable or recurrent GCTs.

Question 882

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with a lytic, eccentrically located lesion in the distal femur extending to the subchondral bone. A biopsy confirms Giant Cell Tumor (GCT) of bone. She is treated preoperatively with denosumab. What is the exact mechanism of action of denosumab in this context?

. Inhibition of RANK ligand (RANKL)
. Direct induction of osteoclast apoptosis
. Inhibition of tyrosine kinase pathways
. Inhibition of vascular endothelial growth factor (VEGF)
. Selective estrogen receptor modulation

Correct Answer & Explanation

. Inhibition of RANK ligand (RANKL)

Explanation

Denosumab is a human monoclonal antibody that specifically binds to and inhibits RANK ligand (RANKL). In Giant Cell Tumors, the neoplastic stromal cells overexpress RANKL, which recruits and activates the multinucleated giant cells (osteoclast-like cells) responsible for massive bone resorption. Denosumab blocks this interaction, reducing the tumor's osteolysis and giant cell population.

Question 883

Topic: Biology, Genetics & Bone Healing
Following arthroscopic rotator cuff repair, healing at the tendon-bone interface progresses through inflammatory, proliferative, and remodeling phases. During the early proliferative phase of healing at the footprint, which type of collagen is predominately synthesized?
. Type I collagen
. Type II collagen
. Type III collagen
. Type IV collagen
. Type X collagen

Correct Answer & Explanation

. Type III collagen

Explanation

During the proliferative phase of tendon-bone healing (and tendon healing in general), fibroblasts rapidly synthesize Type III collagen, which forms disorganized granulation tissue. During the remodeling phase, this is gradually replaced by stronger, highly organized Type I collagen.

Question 884

Topic: Biology, Genetics & Bone Healing

Denosumab is used as a medical treatment for large or unresectable giant cell tumors of bone (GCTB). By what specific molecular mechanism does denosumab halt the progression of this disease?

. Direct induction of apoptosis in the neoplastic mononuclear cells
. Inhibition of RANK ligand (RANKL) expressed by neoplastic mononuclear cells, preventing recruitment of reactive giant cells
. Inhibition of osteoprotegerin (OPG), leading directly to osteoclast death
. Inhibition of vascular endothelial growth factor (VEGF), cutting off tumor vascularity
. Direct binding to the RANK receptor on the surface of normal osteoblasts

Correct Answer & Explanation

. Inhibition of RANK ligand (RANKL) expressed by neoplastic mononuclear cells, preventing recruitment of reactive giant cells

Explanation

Giant cell tumor of bone consists of neoplastic mononuclear stromal cells that overexpress RANKL. This overexpression recruits and activates normal monocytes to become reactive, bone-resorbing multinucleated giant cells. Denosumab is a monoclonal antibody that binds directly to RANKL, halting this interaction and stopping bone destruction.

Question 885

Topic: Biology, Genetics & Bone Healing

During secondary bone healing, endochondral ossification is heavily reliant on the differentiation of mesenchymal stem cells into chondrocytes within the soft callus. Which of the following transcription factors is the primary master regulator driving this chondrogenic differentiation?

. Runx2 (Cbfa1)
. Osterix (Osx)
. Sclerostin
. Sox9
. Beta-catenin

Correct Answer & Explanation

. Sox9

Explanation

Sox9 is the master transcription factor responsible for the commitment and differentiation of mesenchymal stem cells into chondrocytes during endochondral ossification. Runx2 and Osterix are master regulators for osteoblast differentiation.

Question 886

Topic: Biology, Genetics & Bone Healing

Secondary fracture healing, which involves the formation of an intermediate cartilaginous callus, relies heavily on endochondral ossification. Which of the following mechanical environments most strongly promotes this type of bone healing?

. Rigid internal fixation with absolute stability
. Extensive stripping of the local periosteum
. Micromotion at the fracture site providing relative stability
. Application of high-dose local bisphosphonates
. Complete surgical removal of the fracture hematoma

Correct Answer & Explanation

. Micromotion at the fracture site providing relative stability

Explanation

Secondary fracture healing occurs via endochondral ossification, where a cartilage template is first formed and then replaced by bone (callus formation). This process is stimulated by relative stability, which allows for controlled micromotion at the fracture site. Techniques like intramedullary nailing or bridge plating provide relative stability. Absolute stability (e.g., rigid compression plating) eliminates micromotion and promotes primary bone healing via cutting cones, without callus formation.

Question 887

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of bone healing, what is the maximum amount of interfragmentary strain that can be tolerated for primary (direct) bone healing to occur without the formation of a visible fracture callus?

. Less than 2%
. Between 2% and 10%
. Between 10% and 30%
. Greater than 30%
. 100%

Correct Answer & Explanation

. Less than 2%

Explanation

According to Perren's strain theory, primary (direct) bone healing via cutting cones requires absolute stability. This corresponds to an interfragmentary strain of less than 2%. Secondary bone healing (which involves callus formation) occurs at strains between 2% and 10%. Granulation tissue forms at strains up to 100%.

Question 888

Topic: Biology, Genetics & Bone Healing

A 32-year-old female with a recurrent Giant Cell Tumor (GCT) of the distal femur is started on neoadjuvant medical therapy to facilitate joint-salvage surgery. She is given Denosumab, a human monoclonal antibody. What is the exact cellular target and mechanism of action of this medication in the context of GCT?

. Binds to the RANK receptor on the reactive osteoclast-like giant cells
. Binds to RANKL expressed by the neoplastic mononuclear stromal cells
. Acts as an analogue to Osteoprotegerin (OPG) on osteoblasts
. Inhibits Vascular Endothelial Growth Factor (VEGF) preventing angiogenesis
. Inhibits tyrosine kinase receptors in the neoplastic giant cells

Correct Answer & Explanation

. Binds to RANKL expressed by the neoplastic mononuclear stromal cells

Explanation

Denosumab is a monoclonal antibody that targets Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). In Giant Cell Tumor of bone, the neoplastic cells are the mononuclear stromal cells, which express high levels of RANKL. Denosumab binds this RANKL, preventing it from binding to the RANK receptor on the reactive (non-neoplastic) osteoclast-like giant cells, thereby halting their recruitment, maturation, and bone-resorbing activity.

Question 889

Topic: Biology, Genetics & Bone Healing

Bone Morphogenetic Proteins (BMPs), specifically BMP-2 and BMP-7, are utilized clinically for their potent osteoinductive capabilities. Upon binding to their respective cell surface receptors, which specific intracellular signaling pathway is primarily activated to upregulate osteogenic gene transcription?

. Wnt / beta-catenin pathway
. JAK-STAT signaling pathway
. Smad signaling pathway
. MAPK / ERK signaling pathway
. Notch signaling cascade

Correct Answer & Explanation

. Smad signaling pathway

Explanation

BMPs are members of the TGF-beta superfamily. When they bind to their specific serine/threonine kinase transmembrane receptors, they induce phosphorylation of receptor-regulated Smads (R-Smads, such as Smad 1, 5, and 8). These form a complex with the common-partner Smad 4, which then translocates to the nucleus to act as a transcription factor for osteogenic genes (e.g., Runx2).

Question 890

Topic: Biology, Genetics & Bone Healing

Denosumab is an established targeted therapy used in the management of unresectable or recurrent Giant Cell Tumor of Bone (GCTB). What is its precise mechanism of action?

. It binds directly to the ruffled border of mature osteoclasts, inhibiting their function.
. It is a monoclonal antibody that binds to RANKL, preventing activation of the RANK receptor.
. It directly induces apoptosis of the neoplastic mononuclear stromal cells.
. It selectively inhibits vascular endothelial growth factor (VEGF) to starve the tumor.
. It is a tyrosine kinase inhibitor that blocks c-KIT signaling.

Correct Answer & Explanation

. It is a monoclonal antibody that binds to RANKL, preventing activation of the RANK receptor.

Explanation

Denosumab is a fully human monoclonal antibody that binds to Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By binding RANKL, it prevents it from activating the RANK receptor on the surface of osteoclast precursors, thereby inhibiting the formation, function, and survival of the giant osteoclast-like cells characteristic of GCTB.

Question 891

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory regarding fracture healing, what mechanical strain condition within a fracture gap is required to achieve primary (direct) bone healing via Haversian remodeling, bypassing cartilaginous callus formation?

. Strain less than 2%
. Strain between 2% and 10%
. Strain between 10% and 30%
. Strain greater than 30%
. Constant dynamic strain fluctuations

Correct Answer & Explanation

. Strain less than 2%

Explanation

Perren's strain theory posits that primary (direct) bone healing requires absolute stability, defined as a strain environment of < 2%. This environment prevents the disruption of crossing osteons and avoids callus formation. Strain between 2% and 10% allows for secondary healing (callus formation), while strain > 10% leads to nonunion or fibrous tissue formation.

Question 892

Topic: Biology, Genetics & Bone Healing

Bone Morphogenetic Proteins (BMPs) play a crucial role in osteoinduction during fracture healing and spinal fusion. The cellular signaling cascade of BMPs is primarily initiated by the ligand binding to which of the following types of receptors on the cell surface?

. Tyrosine kinase receptors
. G-protein coupled receptors
. Serine/threonine kinase receptors
. Intracellular nuclear receptors
. Ion channel-linked receptors

Correct Answer & Explanation

. Serine/threonine kinase receptors

Explanation

Bone Morphogenetic Proteins (BMPs) are members of the TGF-beta superfamily. They bind to type I and type II transmembrane receptors, which are serine/threonine kinase receptors. Upon ligand binding, these receptors phosphorylate intracellular Smad proteins (typically Smad 1, 5, and 8), which then complex with Smad 4, translocate to the nucleus, and regulate the transcription of osteogenic genes (e.g., Runx2).

Question 893

Topic: Biology, Genetics & Bone Healing

A 28-year-old woman presents with knee pain. Radiographs reveal an eccentric, lytic lesion in the distal femoral epiphysis extending to the subchondral bone, with no sclerotic margin. Biopsy confirms a giant cell tumor of bone (GCTB). Which of the following statements regarding the pathogenesis and targeted medical therapy for this tumor is true?

. The multinucleated giant cells are the primary neoplastic cells and express high levels of RANK
. The mononuclear stromal cells are the primary neoplastic cells and secrete excessive amounts of RANKL
. Imatinib mesylate is the preferred targeted therapy for unresectable lesions
. Denosumab therapy is a monoclonal antibody directed against the RANK receptor on the surface of the mononuclear stromal cells
. The tumor cells characteristically exhibit the t(X;18) chromosomal translocation

Correct Answer & Explanation

. The mononuclear stromal cells are the primary neoplastic cells and secrete excessive amounts of RANKL

Explanation

In Giant Cell Tumor of Bone (GCTB), the neoplastic cells are actually the mononuclear stromal cells, not the multinucleated giant cells. The neoplastic stromal cells secrete large amounts of Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL), which recruits and activates normal osteoclast precursors into the reactive, multinucleated giant cells that cause the characteristic bone destruction. Denosumab is a monoclonal antibody that targets and binds RANKL (not the RANK receptor), inhibiting this process and is used for advanced or unresectable GCTB.

Question 894

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in osteoinduction and fracture healing. They exert their primary intracellular osteogenic effects through which of the following signaling pathways?

. Wnt/beta-catenin pathway
. JAK-STAT pathway
. Smad signaling pathway
. cAMP-dependent protein kinase pathway
. MAPK/ERK pathway

Correct Answer & Explanation

. Smad signaling pathway

Explanation

BMPs are members of the TGF-beta superfamily. Upon binding to their specific transmembrane serine/threonine kinase receptors, they induce phosphorylation of intracellular Smad proteins (specifically receptor-regulated Smads 1, 5, and 8). These form a complex with the co-Smad (Smad 4), which translocates to the nucleus to regulate the transcription of osteogenic target genes like Runx2.

Question 895

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in bone healing and osteoinduction. Following the binding of BMP to its cell surface receptor, which intracellular signaling molecules are directly phosphorylated to translocate to the nucleus and regulate gene expression?

. Wnt proteins
. Smad 1, 5, and 8
. MAP kinases
. Beta-catenin
. RANKL

Correct Answer & Explanation

. Smad 1, 5, and 8

Explanation

BMPs signal primarily through a Smad-dependent pathway. Binding of BMP to its specific serine/threonine kinase receptors leads to the phosphorylation of receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These R-Smads then form a complex with the common-mediator Smad (Smad 4) and translocate into the nucleus to activate the transcription of osteogenic target genes.

Question 896

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with a recurrent Giant Cell Tumor (GCT) of the distal femur. Surgical curettage is deemed highly morbid, and she is started on Denosumab. What is the mechanism of action of this medication?

. It acts as a decoy receptor for macrophage colony-stimulating factor (M-CSF)
. It directly induces apoptosis of the neoplastic stromal cells within the tumor
. It is a monoclonal antibody that binds directly to RANK Ligand (RANKL)
. It is a bisphosphonate that inhibits the farnesyl pyrophosphate synthase pathway
. It selectively modulates estrogen receptors to inhibit osteoclast activity

Correct Answer & Explanation

. It is a monoclonal antibody that binds directly to RANK Ligand (RANKL)

Explanation

Denosumab is a fully human monoclonal antibody that specifically binds to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By binding to RANKL, it prevents RANKL from activating the RANK receptor on the surface of osteoclasts and their precursors, thereby inhibiting osteoclastogenesis and drastically reducing bone resorption in conditions like GCT and osteoporosis.

Question 897

Topic: Biology, Genetics & Bone Healing

In the process of bone remodeling, what is the primary biochemical role of osteoprotegerin (OPG)?

. It binds to RANKL, preventing it from interacting with RANK, thereby inhibiting osteoclast differentiation and activation.
. It binds directly to the RANK receptor on osteoclasts, stimulating osteoclastogenesis.
. It acts as a decoy receptor for macrophage colony-stimulating factor (M-CSF), preventing precursor maturation.
. It upregulates the production of sclerostin by mature osteocytes.
. It is an enzyme secreted by osteoclasts that degrades the organic bone matrix directly.

Correct Answer & Explanation

. It binds to RANKL, preventing it from interacting with RANK, thereby inhibiting osteoclast differentiation and activation.

Explanation

Osteoprotegerin (OPG) is a glycoprotein produced by osteoblasts that acts as a soluble decoy receptor. It competitively binds to RANK Ligand (RANKL), preventing RANKL from binding to the RANK receptor on the surface of osteoclast precursors. This interaction strongly inhibits the differentiation, activation, and survival of osteoclasts, thereby decreasing bone resorption.

Question 898

Topic: Biology, Genetics & Bone Healing

In secondary fracture healing, the cartilaginous soft callus is eventually replaced by woven bone. Which of the following physiological processes predominantly facilitates this specific transformation?

. Intramembranous ossification
. Endochondral ossification
. Creeping substitution
. Appositional bone growth
. Chondrocyte transdifferentiation

Correct Answer & Explanation

. Endochondral ossification

Explanation

Secondary fracture healing occurs in stages: hematoma, soft callus (cartilage), hard callus (woven bone), and remodeling (lamellar bone). The transition from a cartilaginous soft callus to a woven bone hard callus occurs exclusively via endochondral ossification. Intramembranous ossification occurs directly subperiosteally without a cartilage intermediate.

Question 899

Topic: Biology, Genetics & Bone Healing

A 28-year-old female presents with a lytic lesion in the distal femur. Biopsy confirms a Giant Cell Tumor (GCT) of bone. She is treated with Denosumab prior to planned surgical curettage to facilitate joint preservation. What is the precise mechanism of action of Denosumab?

. Monoclonal antibody that binds directly to RANK receptors on osteoclasts
. Monoclonal antibody that binds to RANKL, preventing it from activating RANK
. Tyrosine kinase inhibitor targeting VEGF
. Bisphosphonate analogue that induces osteoclast apoptosis
. Selective estrogen receptor modulator (SERM)

Correct Answer & Explanation

. Monoclonal antibody that binds to RANKL, preventing it from activating RANK

Explanation

Denosumab is a fully human monoclonal antibody that binds to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By binding to RANKL, it prevents RANKL from interacting with the RANK receptor on the surface of osteoclasts and their precursors, thereby inhibiting osteoclastogenesis and downregulating bone resorption. Giant cell tumors are rich in RANKL-expressing stromal cells.

Question 900

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a critical role in osteoinduction and are heavily utilized in spinal fusion. Recombinant human BMP-2 acts primarily through binding to cell surface receptors, initiating an intracellular signaling cascade. Which of the following molecules act as the primary intracellular signaling pathway for BMP-2?

. Wnt and beta-catenin
. JAK and STAT
. Smad 1, 5, and 8
. MAP kinase and ERK
. RANK and RANKL

Correct Answer & Explanation

. Smad 1, 5, and 8

Explanation

Bone morphogenetic proteins (BMPs) are members of the TGF-beta superfamily. They bind to serine/threonine kinase receptors on the cell surface, which then phosphorylate the receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These complex with Smad 4 to enter the nucleus and regulate the transcription of osteogenic genes like Runx2.

Test Yourself

Switch to an interactive, timed exam simulation to truly master this topic.

On this Page